Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Psyence acquires fellow psilocybin biotech Clairvoyant
Psyence Biomedical is paying $500,000 in shares to acquire Clairvoyant Therapeutics and its phase 2-stage alcohol use disorder candidate.
James Waldron
Sep 6, 2024 9:25am
J&J ordered to pay $1B over fallout from Auris robotics deal
Sep 5, 2024 4:10pm
Medera plans SPAC merger to advance cardiac gene therapies
Sep 5, 2024 10:50am
EU court hands Illumina consolation prize over Grail deal
Sep 3, 2024 12:21pm
Getinge buys organ transplant specialist Paragonix for $477M
Aug 26, 2024 2:00pm
A VC recovery may be coming in Europe: PitchBook
Aug 22, 2024 3:00pm